Access first
OpenAI’s October 30 notes introduce GPT-6 Rosalind Research, a model aimed at life-sciences work. The announced rollout is limited to approved Research organizations. The dated announcement does not establish an exact first-public hour. [1]
Access requires both organization and user approval. Discovery approval does not confer Research access. Approved users find it in Work and Codex, not the Chat tab; API access needs separate approval. Enterprise begins with a two-week Admin Preview, off by default, even for previously approved organizations. The guide limits approved API use to internal research and excludes customer-facing or external commercial applications. Existing approved workflows can retain GPT-5.5 Rosalind Research. [2]
Our take
Check approval for the specific user, product, and project. Keep scientific review and data governance in the workflow. We reviewed documentation without accessing the model.